Abstract: An automatic transport device for cleaning machines includes a transport base. A lifting-lowering assembly and a tray are provided on the transport base. The tray is connected to the transport base through the lifting-lowering assembly, and can be driven by the lifting-lowering assembly to reciprocate in a height direction. A top surface of the tray is provided with a translation assembly for transferring the shelf to the transport platform. A first mounting cavity is provided at each of front and rear ends of the tray. The translation assembly is connected to a side wall of the first mounting cavity. A second mounting cavity is provided at each of right and left ends of the tray. The second mounting cavity is provided with a limiting assembly, a lifting-lowering sensing assembly and a distance sensing assembly. An interactive system is provided in the transport base.

Abstract: The present invention provides a substrate supporting apparatus having a spin chuck and a plurality of locating pins. The spin chuck configured to support and rotate a substrate has a supporting surface. The locating pins are disposed at the periphery of the supporting surface for limiting the substrate horizontal displacement. The supporting surface defines a first annular region. The first annular region is divided into a plurality of pin regions and a plurality of non-pin regions. The pin regions and the non-pin regions are arranged alternatively in a circumferential direction of the first annular region. Each of the pin regions is corresponding to one locating pin. A plurality of Bernoulli holes are set in the first annular region and is configured as an uneven structure in the first annular region so as to supply stronger gas flow in the pin regions than in the non-pin regions.

Abstract: An automatic transport device for cleaning machines includes a transport base. A lifting-lowering assembly and a tray are provided on the transport base. The tray is connected to the transport base through the lifting-lowering assembly, and can be driven by the lifting-lowering assembly to reciprocate in a height direction. A top surface of the tray is provided with a translation assembly for transferring the shelf to the transport platform. A first mounting cavity is provided at each of front and rear ends of the tray. The translation assembly is connected to a side wall of the first mounting cavity. A second mounting cavity is provided at each of right and left ends of the tray. The second mounting cavity is provided with a limiting assembly, a lifting-lowering sensing assembly and a distance sensing assembly. An interactive system is provided in the transport base.

Abstract: The embodiment of the present disclosure provides a time code synchronization method, which includes following steps of: determining a target master node and one or more target slave nodes of a network system among the plurality of nodes; periodically sending a data packet to the one or more target slave nodes by the target master node, wherein the data packet includes a first time code and serial number information of the target master node; compensating the first time code according to the serial number information to obtain a second time code, and synchronizing the second time code by the one or more target slave nodes.

Abstract: The present invention belongs to the technical field of audio equipment, and particularly relates to a wireless microphone device and a use method therefor. In the wireless microphone device, a main control unit controls a transmitter working mode in which an input unit, an output unit, a time code unit, a conversion modulation unit, a storage unit and a radio-frequency unit work together; or a receiver working mode in which the input unit, the output unit, the time code unit, the conversion modulation unit and the radio frequency unit work together; or a time code generator working mode in which the output unit and the time code unit work together; or a sound recorder working mode in which the input unit, the time code unit, the conversion modulation unit and the storage unit work together.

Abstract: The embodiment of the present disclosure provides a time code synchronization method, which includes following steps of: determining a target master node and one or more target slave nodes of a network system among the plurality of nodes; periodically sending a data packet to the one or more target slave nodes by the target master node, wherein the data packet includes a first time code and serial number information of the target master node; compensating the first time code according to the serial number information to obtain a second time code, and synchronizing the second time code by the one or more target slave nodes.

Abstract: Disclosed are an EGFR inhibitor free base or acid salt polycrystalline form, a preparation method therefor, and an application thereof. The present invention specifically relates to an N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)actylamide free base or acid salt polycrystalline form, a preparation method therefor, and an application of the polycrystalline form in preparing a drug for treating an EGFR mutant activity-mediated disease. The present invention is used for inhibiting the activity of an L858R EGFR mutant, a T790M EGFR mutant and an exon 19 deletion activating mutant etc., may be widely applied in preventing and treating cancer, especially non-small cell lung cancer and other related diseases, and is expected to develop into a new generation of EGFR inhibitors.

Abstract: Disclosed are an EGFR inhibitor free base or acid salt polycrystalline form, a preparation method therefor, and an application thereof. The present invention specifically relates to an N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide free base or acid salt polycrystalline form, a preparation method therefor, and an application of the polycrystalline form in preparing a drug for treating an EGFR mutant activity-mediated disease. The present invention is used for inhibiting the activity of an L858R EGFR mutant, a T790M EGFR mutant and an exon 19 deletion activating mutant etc., may be widely applied in preventing and treating cancer, especially non-small cell lung cancer and other related diseases, and is expected to develop into a new generation of EGFR inhibitors.

Abstract: Disclosed are an EGFR inhibitor free base or acid salt polycrystalline form, a preparation method therefor, and an application thereof. The present invention specifically relates to an N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide free base or acid salt polycrystalline form, a preparation method therefor, and an application of the polycrystalline form in preparing a drug for treating an EGFR mutant activity-mediated disease. The present invention is used for inhibiting the activity of an L858R EGFR mutant, a T790M EGFR mutant and an exon 19 deletion activating mutant etc., may be widely applied in preventing and treating cancer, especially non-small cell lung cancer and other related diseases, and is expected to develop into a new generation of EGFR inhibitors.

Abstract: Disclosed are an EGFR inhibitor free base or acid salt polycrystalline form, a preparation method therefor, and an application thereof. The present invention specifically relates to an N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide free base or acid salt polycrystalline form, a preparation method therefor, and an application of the polycrystalline form in preparing a drug for treating an EGFR mutant activity-mediated disease. The present invention is used for inhibiting the activity of an L858R EGFR mutant, a T790M EGFR mutant and an exon 19 deletion activating mutant etc., may be widely applied in preventing and treating cancer, especially non-small cell lung cancer and other related diseases, and is expected to develop into a new generation of EGFR inhibitors.

Abstract: Disclosed are an EGFR inhibitor free base or acid salt polycrystalline form, a preparation method therefor, and an application thereof. The present invention specifically relates to an N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide free base or acid salt polycrystalline form, a preparation method therefor, and an application of the polycrystalline form in preparing a drug for treating an EGFR mutant activity-mediated disease. The present invention is used for inhibiting the activity of an L858R EGFR mutant, a T790M EGFR mutant and an exon 19 deletion activating mutant etc., may be widely applied in preventing and treating cancer, especially non-small cell lung cancer and other related diseases, and is expected to develop into a new generation of EGFR inhibitors.

Abstract: A bi-material connecting rod is disclosed herein. The connecting rod includes a crank end that formed from a first material, and a shank connected to the crank end that is formed from a second material. The connecting rod further includes a pin end adjacent to the shank and opposite from the crank end that can be formed from the first material, second powder-metal material, or a third material. Also disclosed herein is a method for making a bi-material connecting rod.

Abstract: A process of forming powder metal components which minimizes decarburization and oxidation of the component prior to final forging. The process begins by molding powder metal material into a preform configuration. The preform is delubricated to extract lubricant found in the pores of the preform. Passing the preform through a shot peening operation closes a majority of the surface pores creating a densified layer within which interconnected pores are eliminated. Following post-delubrication peening (PDP), the component is sintered and then forged into its final configuration.